A nurse-facilitated oral chemotherapy care model has improved delivery times, patient satisfaction, and co-pay support at a Connecticut cancer hospital.
Follow-up telephone calls and clinician assessment may be an effective strategy to identify early which patients require support with adhering to oral cancer therapy.
A nurse-managed precision cancer treatment education resource center may improve information dissemination about genomic health and targeted therapy.
Instituting a Chemotherapy Safety Committee and developing an administration process successfully standardized the inpatient oral chemotherapy administration process.
A formal nursing practice was developed to promote patient safety and adherence with oral chemotherapy.
Implementation of the Massey Bedside Swallowing Screen and strict oral care regimens in high-risk patients reduced the rate of hospital-acquired pneumonia (HAP) at an oncology treatment center.
A central venous catheter self-management education program is an effective nursing intervention to promote long-term self-management of a CVC for discharged patients with cancer.
The formation of a multidisplinary taskforce and the introduction of improved products successfully reduced the rates of catheter associated urinary tract infections (CAUTI) at an oncology hospital.
Daily chlorhexidine gluconate bathing on all patients with ports and tunneled catheters decreased the rates of CLABSI on an inpatient oncology unit.
Formation of a multidisciplinary team and a focus on evidence-based interventions successfully reduced the rate of central line bloodstream infections (CLABSI) on an inpatient oncology unit.
PICC Claiming Antithrombogenic, Antimicrobial Properties Failed to Reduce Thromboses, Line DysfunctionApril 30, 2016
A PICC with preclinical data claiming antithrombogenic and antimicrobial properties failed to reduce the rate of CLABSI or catheter-related thromboses compared with a standard PICC.
Algorithm Plots Efficient Course for Assessing Immune-related Adverse Events in Cancer ImmunotherapyApril 29, 2016
Use of a collaborative team dedicated to managing immune-related adverse events (irAEs) enabled prompt recognition and safe, successful management in patients receiving immunotherapy for cancer.
The oncology nurse plays a pivotal role in the management of abdominal compartment syndrome (ACS) by focusing on risk assessment and early identification of clinical signs and symptoms.
Incorporating a modified MASCC grading tool for evaluating epidermal growth factor receptor inhibitor (EGFRI) toxicities and quality of life improved the rate of skin assessments and documentation.
Oncology nurses are in an ideal position to educate patients with gastrointestinal malignancies and PVT about risk factors, clinical presentation, complications, and treatment options to prevent further extension of the clot.
All opioids are currently recommended for breakthrough cancer pain and clinicians may use the opioid of their choice.
Treatment of breakthrough cancer pain is an important component of care for patients, and nurses should consider various factors when titrating the dose of fentanyl sublingual spray to an effective dose.
High-risk medications can increase falls in patients undergoing treatment for malignant hematology, but implementing risk-specific fall prevention strategies can ameliorate the effects of the drugs.
A research unit created by oncology nurses trains nurses to provide high quality care to patients in oncology clinical trials.
An innovative and robust nurse residency program that includes an evidence-based practice project, can impact oncology nursing practice and outcomes.
A clinical trial infusion nurse orientation improves training for nurses so they can better care for patients participating in investigational trials.
Simulation-based learning improved the confidence and skills of oncology nurses in chemotherapy-biotherapy administration.
A unique and comprehensive approach to training oncology nurses for transition to a new hospital with inpatient and outpatient services improved their confidence in working in the new building.
Patient responses to the medication questions on the HCAHPS survey demonstrate improved understanding of their medications after implementation of an improved patient education process.
A nurse-directed independent survey for patient feedback can inform measurable improvements in patient education and satisfaction survey scores.
Comprehensive patient education that includes information on breast reconstruction, with photos, can help women with breast cancer make more informed decisions about their treatment options.
Oncology Nurse-led Team Can Reduce Treatment Delays, Hospitalizations for Patients With Head and Neck CancerApril 28, 2016
An oncology nurse-led team approach can reduce treatment delays and hospitalizations and improve quality of care for patients with head and neck cancer.
An AYA patient survivorship program jointly designed by a cancer institute and a community organization educates patients about their oncologic history and the effects of therapy, as well as provides resources to improve quality of life.
Oncology nurses can play a pivotal role in diagnosis and management of the rare neuroendocrine tumors pheochromocytomas and paragangliomas.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
- Immunotherapy and the Future of Prostate Cancer Treatment
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|